Programmable RNA therapeutics: from intracellular sensing to cell-specific delivery
Nucleic Acid Insights · 28.05.2026 · 3 (4) · 219–225
DOI: 10.18609/nai.2026.028 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acid Insights, online erschienen am 28.05.2026. Verfasst von Charannya Sozheesvari Subhramanyam. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
“...one major sign of success would be havingmultiple clinically validated platforms that can reproducibly deliver different RNA cargoes...”Jokūbas Leikauskas, Editor, Nucleic Acid Insights, speaks to Charannya Sozheesvari Subhramanyam, Scientist, A*STAR Institute of Molecular and Cell Biology, about the current challenges and emerging strategies in achieving tissue- and cell-specific delivery of RNA therapeutics, exploring how programmable RNA sensing technologies could unlock the next level of precision in targeted RNA medicine.
Zitieren
APA
Subhramanyam, C. S. (2026). Programmable RNA therapeutics: from intracellular sensing to cell-specific delivery. Nucleic Acid Insights, 3(4), 219–225. https://doi.org/10.18609/nai.2026.028
Vancouver
Subhramanyam CS. Programmable RNA therapeutics: from intracellular sensing to cell-specific delivery. Nucleic Acid Insights. 2026;3(4):219–225. doi:10.18609/nai.2026.028
BibTeX
@article{Subhramanyam2026,
author = {Subhramanyam, Charannya Sozheesvari},
title = {Programmable RNA therapeutics: from intracellular sensing to cell-specific delivery},
journal = {Nucleic Acid Insights},
year = {2026},
volume = {3},
number = {4},
pages = {219–225},
doi = {10.18609/nai.2026.028}
}
EUVIMED